Testo Saveris to highlight value of environmental monitoring at LogiPharma 2026

Testo Saveris to highlight value of environmental monitoring at LogiPharma 2026

Testo Saveris will showcase digital environmental monitoring at LogiPharma 2026. The company will demonstrate how real-time temperature and humidity monitoring can strengthen compliance, reduce deviation risk, and improve pharmaceutical supply chain resilience.


Instrumentation and environmental monitoring solutions specialist Testo Saveris is returning to LogiPharma in April to highlight how digital environmental monitoring can help the pharmaceutical industry make its supply chains more resilient, compliant and data-driven.

The company’s stand will demonstrate how to harness temperature and humidity data to drive actionable insights, from removing blind spots to enabling real-time control.

Having made its debut as an event sponsor in 2025, Testo Saveris sees the value of LogiPharma as a place to build partnerships.  “The companies we spoke to last year were excited to learn how we integrate sensors, software and services to be a “All in one” partner for environmental monitoring,” said Dr. Fábio A. S. Leite – Subject Matter Expert Pharma, Testo Saveris GmbH.

“We’re delighted to be back at LogiPharma’s new venue in Vienna to build on these conversations and provide tangible evidence of what’s possible through robust environmental monitoring.”  

Testo Saveris will be showcasing examples of best practice from real customer projects in cold storage, ambient warehouses and transport. Through these case studies, visitors to LogiPharma can see how automated environmental monitoring reduces manual checks, documentation effort and deviation risk in pharma logistics. 

The company’s systems are designed to support GxP and 21 CFR Part 11 requirements, including audit-ready reporting and data integrity by design. As such, the results have helped customers to avoid excursions and maintain data integrity, all while providing a scalable future proof solution. 

“We are trusted by leading pharma and biotech companies for environmental monitoring across multiple sites, enabling a standardised, global monitoring platform that can support network-wide harmonisation and faster rollouts,” added Dr. Fábio A. S. Leite – Subject Matter Expert Pharma, Testo Saveris GmbH. 

“We welcome delegates to bring their specific challenges to stand 117 to discuss directly with our pharma specialists.”


Stories for you


  • SpaceLocker launches first shared satellite mission

    SpaceLocker launches first shared satellite mission

    SpaceLocker has launched its first fully owned shared satellite mission. The move shifts the French company from hosted payload specialist to operator, with a multi-customer CubeSat designed to cut cost and time to orbit.


  • Cold Chain Technologies sets net zero goal

    Cold Chain Technologies sets net zero goal

    Cold Chain Technologies has set a 2050 net zero target. The commitment builds on recyclable and reusable thermal packaging, landfill reduction, and digital shipment monitoring.